When.com Web Search

  1. Ads

    related to: biological patents by state

Search results

  1. Results From The WOW.Com Content Network
  2. Biological patents in the United States - Wikipedia

    en.wikipedia.org/wiki/Biological_patents_in_the...

    As with all utility patents in the United States, a biological patent provides the patent holder with the right to exclude others from making, using, selling, or importing the claimed invention or discovery in biology for a limited period of time - for patents filed after 1998, 20 years from the filing date.

  3. Biological patent - Wikipedia

    en.wikipedia.org/wiki/Biological_patent

    A biological patent is a patent on an invention in the field of biology that by law ... In the United States, up until 2013 natural biological substances themselves ...

  4. List of United States patent law cases - Wikipedia

    en.wikipedia.org/wiki/List_of_United_States...

    This is a list of notable patent law cases in the United States in chronological order. The cases have been decided notably by the United States Supreme Court , the United States Court of Appeals for the Federal Circuit (CAFC) or the Board of Patent Appeals and Interferences (BPAI).

  5. Patent - Wikipedia

    en.wikipedia.org/wiki/Patent

    The initiative launched in 2004 and involves two phases: documenting the damage caused by these patents, [145] and submitting challenges to the United States Patent and Trademark Office (USPTO). [146] [147] Patent critic, Joseph Stiglitz has proposed Prizes as an alternative to patents in order to further advance solutions to global problems ...

  6. Patome - Wikipedia

    en.wikipedia.org/wiki/Patome

    Patome is a database of biological sequence data of issued patents and/or published ... Patents; Gene patent; References. a b External links. https://web.archive.org ...

  7. Association for Molecular Pathology v. Myriad Genetics, Inc.

    en.wikipedia.org/wiki/Association_for_Molecular...

    Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), was a Supreme Court case, which decided that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated.” [1] However, the Court allowed patenting of complementary DNA, which contains exactly the same protein-coding base pair sequence as the natural ...